By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Waters has sold $100 million worth of 3.75 percent Series A Senior Notes due Feb. 1, 2015, in a private placement with institutional purchasers, the firm said in a filing with the US Securities and Exchange Commission today.

The placement was made yesterday and is the first of two senior notes offerings. In the second, expected to take place on March 1, 2010, Waters intends to sell $100 million worth of 5 percent Series B Senior Notes due Feb. 1, 2020.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.